Genomic Valley Biotech has informed that the meeting of the Board of Directors of the Company is scheduled on 12/11/2021 to consider and approve the Un-Audited Financial Results for the quarter and six months ended September 30, 2021. Pursuant to the Code of Conduct for Prevention of Insider Trading of the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the trading window for the purpose of trading in the securities of the Company by its Designated persons has been closed from 01st October, 2021 till 48 hours of declaration of results i.e. 14th November, 2021.
The above information is a part of company’s filings submitted to BSE.